Lingxia Li1, Shuan Jin2, Yingmin Zhang1. 1. Department of Respiratory Diseases, First Affiliated Hospital of Henan University of Science and Technology Luoyang, China. 2. Department of Anesthesiology, Jinan Central Hospital, Shandong University Jinan, China.
Abstract
OBJECTIVE: To explore the effect of bone marrow mesenchymal stem cells (MSCs) on endotoxin-induced acute lung injury in mice and verify the role of exosome. METHODS: Exosome was isolated from the culture supernatant of MSC. For ischemic preconditioning, MSCs were subjected to anoxia for 0 min (MSCs group), 30 min (MSCs(IPC-30) group), 60 min (MSCs(IPC-60) group) and 90 min (MSCs(IPC 90) group), and then used to treat endotoxin-injured mice. The exosome from the optimal group was used to treat endotoxin-injured mice. In addition, the exosome from the optimal group was also used to treat the endotoxin-stimulated RAW 264.7 cells for 6 h and 12 h. RESULTS: CD63 positive exosome were acquired through ExoQuick kits. Administration of MSCs, MSCs(IPC-30), MSCs(IPC-60) and MSCs(IPC-90) could reduce the level of white blood cells (WBC) and neutrophils into the bronchoalveolar lavage (BAL) fluid of endotoxin-injured mice, and the MSCIPC-60 group had the greatest reduction, which reduced WBC by 57% and neutrophils by 55%. Administration of MSCs(IPC-60) exosome could also reduce the level of WBC, neutrophils, MIP-2 and penetration protein into the BAL fluid of endotoxin-injured mice, which had the same effect as MSCs(IPC-60) and showed a dose dependent, compared to MSCs exosome. In addition, MSCs(IPC-60) exosome were used to treat endotoxin-stimulated RAW 264.7 cells, and the level of TNFα at 6 h and 12 h was significantly reduced, while the level of IL-10 at 12 h increased. CONCLUSION: Ischemic preconditioning for 60 min can potentiates the protective effect of MSC on endotoxin-induced Acute Lung Injury through the secretion of Exosome.
OBJECTIVE: To explore the effect of bone marrow mesenchymal stem cells (MSCs) on endotoxin-induced acute lung injury in mice and verify the role of exosome. METHODS: Exosome was isolated from the culture supernatant of MSC. For ischemic preconditioning, MSCs were subjected to anoxia for 0 min (MSCs group), 30 min (MSCs(IPC-30) group), 60 min (MSCs(IPC-60) group) and 90 min (MSCs(IPC 90) group), and then used to treat endotoxin-injured mice. The exosome from the optimal group was used to treat endotoxin-injured mice. In addition, the exosome from the optimal group was also used to treat the endotoxin-stimulated RAW 264.7 cells for 6 h and 12 h. RESULTS:CD63 positive exosome were acquired through ExoQuick kits. Administration of MSCs, MSCs(IPC-30), MSCs(IPC-60) and MSCs(IPC-90) could reduce the level of white blood cells (WBC) and neutrophils into the bronchoalveolar lavage (BAL) fluid of endotoxin-injured mice, and the MSCIPC-60 group had the greatest reduction, which reduced WBC by 57% and neutrophils by 55%. Administration of MSCs(IPC-60) exosome could also reduce the level of WBC, neutrophils, MIP-2 and penetration protein into the BAL fluid of endotoxin-injured mice, which had the same effect as MSCs(IPC-60) and showed a dose dependent, compared to MSCs exosome. In addition, MSCs(IPC-60) exosome were used to treat endotoxin-stimulated RAW 264.7 cells, and the level of TNFα at 6 h and 12 h was significantly reduced, while the level of IL-10 at 12 h increased. CONCLUSION:Ischemic preconditioning for 60 min can potentiates the protective effect of MSC on endotoxin-induced Acute Lung Injury through the secretion of Exosome.
Entities:
Keywords:
Ischemic preconditioning; and acute lung injury; bone marrow mesenchymal stem cells; exosome
Authors: Guangxi Li; Michael Malinchoc; Rodrigo Cartin-Ceba; Chakradhar V Venkata; Daryl J Kor; Steve G Peters; Rolf D Hubmayr; Ognjen Gajic Journal: Am J Respir Crit Care Med Date: 2010-08-06 Impact factor: 21.405
Authors: Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson Journal: N Engl J Med Date: 2005-10-20 Impact factor: 91.245
Authors: Ying-Gang Zhu; Xiao-Mei Feng; Jason Abbott; Xiao-Hui Fang; Qi Hao; Antoine Monsel; Jie-Ming Qu; Michael A Matthay; Jae W Lee Journal: Stem Cells Date: 2014-01 Impact factor: 6.277
Authors: Gabrielle Lapping-Carr; Abdelnaby Khalyfa; Stephanie Rangel; Wendy Darlington; Eric C Beyer; Radhika Peddinti; John M Cunningham; David Gozal Journal: Pediatr Pulmonol Date: 2017-05-09
Authors: Soudeh Ghafouri-Fard; Vahid Niazi; Bashdar Mahmud Hussen; Mir Davood Omrani; Mohammad Taheri; Abbas Basiri Journal: Front Cell Dev Biol Date: 2021-07-07
Authors: Harry H Qin; Céline Filippi; Song Sun; Sharon Lehec; Anil Dhawan; Robin D Hughes Journal: Stem Cell Res Ther Date: 2015-12-01 Impact factor: 6.832
Authors: Muhammad Nawaz; Farah Fatima; Krishna C Vallabhaneni; Patrice Penfornis; Hadi Valadi; Karin Ekström; Sharad Kholia; Jason D Whitt; Joseph D Fernandes; Radhika Pochampally; Jeremy A Squire; Giovanni Camussi Journal: Stem Cells Int Date: 2015-11-16 Impact factor: 5.443
Authors: Mona G Alharbi; Seok Hee Lee; Aaser M Abdelazim; Islam M Saadeldin; Mosleh M Abomughaid Journal: Biomed Res Int Date: 2021-07-20 Impact factor: 3.411